Global Neurostimulation Devices Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
ReportID: 541717
|
Published Date: 11/08/2021
|
No. of Pages: 123
|
Categories: Life Sciences
|
Format : 
The global Neurostimulation Devices market was valued at 410.12 Million USD in 2020 and will grow with a CAGR of 11.35% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016. Implantable neurostimulation devices are widely used to treat pain management, parkinson`s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%. North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016. North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%. Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
By Market Verdors:
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
By Types:
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
By Applications:
Pain Management
Parkinson`s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.The global average price of implantable neurostimulation devices is in the fluctuating trend, 22.10 K USD/Unit in 2012 to 21.24 K USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of implantable neurostimulation devices includes spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS) and other type, and the proportion of spinal cord stimulation (SCS) in 2016 is about 57%, and the proportion is in increasing trend from 2012 to 2016. Implantable neurostimulation devices are widely used to treat pain management, parkinson`s disease, urinary and fecal incontinence, epilepsy, gastroparesis and other field. The most proportion of implantable neurostimulation devices is used for pain management, and the consumption proportion in 2016 is about 55%. North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016. North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%. Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
By Market Verdors:
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
By Types:
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
By Applications:
Pain Management
Parkinson`s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027
1.5.1 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Neurostimulation Devices Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Neurostimulation Devices Industry Impact
Chapter 2 Global Neurostimulation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neurostimulation Devices (Volume and Value) by Type
2.1.1 Global Neurostimulation Devices Consumption and Market Share by Type (2016-2021)
2.1.2 Global Neurostimulation Devices Revenue and Market Share by Type (2016-2021)
2.2 Global Neurostimulation Devices (Volume and Value) by Application
2.2.1 Global Neurostimulation Devices Consumption and Market Share by Application (2016-2021)
2.2.2 Global Neurostimulation Devices Revenue and Market Share by Application (2016-2021)
2.3 Global Neurostimulation Devices (Volume and Value) by Regions
2.3.1 Global Neurostimulation Devices Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Neurostimulation Devices Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Neurostimulation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Neurostimulation Devices Consumption by Regions (2016-2021)
4.2 North America Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.10 South America Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Neurostimulation Devices Market Analysis
5.1 North America Neurostimulation Devices Consumption and Value Analysis
5.1.1 North America Neurostimulation Devices Market Under COVID-19
5.2 North America Neurostimulation Devices Consumption Volume by Types
5.3 North America Neurostimulation Devices Consumption Structure by Application
5.4 North America Neurostimulation Devices Consumption by Top Countries
5.4.1 United States Neurostimulation Devices Consumption Volume from 2016 to 2021
5.4.2 Canada Neurostimulation Devices Consumption Volume from 2016 to 2021
5.4.3 Mexico Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 6 East Asia Neurostimulation Devices Market Analysis
6.1 East Asia Neurostimulation Devices Consumption and Value Analysis
6.1.1 East Asia Neurostimulation Devices Market Under COVID-19
6.2 East Asia Neurostimulation Devices Consumption Volume by Types
6.3 East Asia Neurostimulation Devices Consumption Structure by Application
6.4 East Asia Neurostimulation Devices Consumption by Top Countries
6.4.1 China Neurostimulation Devices Consumption Volume from 2016 to 2021
6.4.2 Japan Neurostimulation Devices Consumption Volume from 2016 to 2021
6.4.3 South Korea Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 7 Europe Neurostimulation Devices Market Analysis
7.1 Europe Neurostimulation Devices Consumption and Value Analysis
7.1.1 Europe Neurostimulation Devices Market Under COVID-19
7.2 Europe Neurostimulation Devices Consumption Volume by Types
7.3 Europe Neurostimulation Devices Consumption Structure by Application
7.4 Europe Neurostimulation Devices Consumption by Top Countries
7.4.1 Germany Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.2 UK Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.3 France Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.4 Italy Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.5 Russia Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.6 Spain Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.7 Netherlands Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.8 Switzerland Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.9 Poland Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 8 South Asia Neurostimulation Devices Market Analysis
8.1 South Asia Neurostimulation Devices Consumption and Value Analysis
8.1.1 South Asia Neurostimulation Devices Market Under COVID-19
8.2 South Asia Neurostimulation Devices Consumption Volume by Types
8.3 South Asia Neurostimulation Devices Consumption Structure by Application
8.4 South Asia Neurostimulation Devices Consumption by Top Countries
8.4.1 India Neurostimulation Devices Consumption Volume from 2016 to 2021
8.4.2 Pakistan Neurostimulation Devices Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Neurostimulation Devices Market Analysis
9.1 Southeast Asia Neurostimulation Devices Consumption and Value Analysis
9.1.1 Southeast Asia Neurostimulation Devices Market Under COVID-19
9.2 Southeast Asia Neurostimulation Devices Consumption Volume by Types
9.3 Southeast Asia Neurostimulation Devices Consumption Structure by Application
9.4 Southeast Asia Neurostimulation Devices Consumption by Top Countries
9.4.1 Indonesia Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.2 Thailand Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.3 Singapore Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.4 Malaysia Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.5 Philippines Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.6 Vietnam Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.7 Myanmar Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 10 Middle East Neurostimulation Devices Market Analysis
10.1 Middle East Neurostimulation Devices Consumption and Value Analysis
10.1.1 Middle East Neurostimulation Devices Market Under COVID-19
10.2 Middle East Neurostimulation Devices Consumption Volume by Types
10.3 Middle East Neurostimulation Devices Consumption Structure by Application
10.4 Middle East Neurostimulation Devices Consumption by Top Countries
10.4.1 Turkey Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.3 Iran Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.5 Israel Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.6 Iraq Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.7 Qatar Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.8 Kuwait Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.9 Oman Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 11 Africa Neurostimulation Devices Market Analysis
11.1 Africa Neurostimulation Devices Consumption and Value Analysis
11.1.1 Africa Neurostimulation Devices Market Under COVID-19
11.2 Africa Neurostimulation Devices Consumption Volume by Types
11.3 Africa Neurostimulation Devices Consumption Structure by Application
11.4 Africa Neurostimulation Devices Consumption by Top Countries
11.4.1 Nigeria Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.2 South Africa Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.3 Egypt Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.4 Algeria Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.5 Morocco Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 12 Oceania Neurostimulation Devices Market Analysis
12.1 Oceania Neurostimulation Devices Consumption and Value Analysis
12.2 Oceania Neurostimulation Devices Consumption Volume by Types
12.3 Oceania Neurostimulation Devices Consumption Structure by Application
12.4 Oceania Neurostimulation Devices Consumption by Top Countries
12.4.1 Australia Neurostimulation Devices Consumption Volume from 2016 to 2021
12.4.2 New Zealand Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 13 South America Neurostimulation Devices Market Analysis
13.1 South America Neurostimulation Devices Consumption and Value Analysis
13.1.1 South America Neurostimulation Devices Market Under COVID-19
13.2 South America Neurostimulation Devices Consumption Volume by Types
13.3 South America Neurostimulation Devices Consumption Structure by Application
13.4 South America Neurostimulation Devices Consumption Volume by Major Countries
13.4.1 Brazil Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.2 Argentina Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.3 Columbia Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.4 Chile Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.5 Venezuela Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.6 Peru Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.8 Ecuador Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Neurostimulation Devices Business
14.1 Medtronic
14.1.1 Medtronic Company Profile
14.1.2 Medtronic Neurostimulation Devices Product Specification
14.1.3 Medtronic Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Boston Scientific
14.2.1 Boston Scientific Company Profile
14.2.2 Boston Scientific Neurostimulation Devices Product Specification
14.2.3 Boston Scientific Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 St. Jude Medical (Abbott)
14.3.1 St. Jude Medical (Abbott) Company Profile
14.3.2 St. Jude Medical (Abbott) Neurostimulation Devices Product Specification
14.3.3 St. Jude Medical (Abbott) Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 LivaNova
14.4.1 LivaNova Company Profile
14.4.2 LivaNova Neurostimulation Devices Product Specification
14.4.3 LivaNova Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Nevro
14.5.1 Nevro Company Profile
14.5.2 Nevro Neurostimulation Devices Product Specification
14.5.3 Nevro Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 NeuroPace
14.6.1 NeuroPace Company Profile
14.6.2 NeuroPace Neurostimulation Devices Product Specification
14.6.3 NeuroPace Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Beijing Pins
14.7.1 Beijing Pins Company Profile
14.7.2 Beijing Pins Neurostimulation Devices Product Specification
14.7.3 Beijing Pins Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Synapse Biomedical
14.8.1 Synapse Biomedical Company Profile
14.8.2 Synapse Biomedical Neurostimulation Devices Product Specification
14.8.3 Synapse Biomedical Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Neurostimulation Devices Market Forecast (2022-2027)
15.1 Global Neurostimulation Devices Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Neurostimulation Devices Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Neurostimulation Devices Value and Growth Rate Forecast (2022-2027)
15.2 Global Neurostimulation Devices Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Neurostimulation Devices Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Neurostimulation Devices Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Neurostimulation Devices Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Neurostimulation Devices Consumption Forecast by Type (2022-2027)
15.3.2 Global Neurostimulation Devices Revenue Forecast by Type (2022-2027)
15.3.3 Global Neurostimulation Devices Price Forecast by Type (2022-2027)
15.4 Global Neurostimulation Devices Consumption Volume Forecast by Application (2022-2027)
15.5 Neurostimulation Devices Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027
1.5.1 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Neurostimulation Devices Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Neurostimulation Devices Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Neurostimulation Devices Industry Impact
Chapter 2 Global Neurostimulation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neurostimulation Devices (Volume and Value) by Type
2.1.1 Global Neurostimulation Devices Consumption and Market Share by Type (2016-2021)
2.1.2 Global Neurostimulation Devices Revenue and Market Share by Type (2016-2021)
2.2 Global Neurostimulation Devices (Volume and Value) by Application
2.2.1 Global Neurostimulation Devices Consumption and Market Share by Application (2016-2021)
2.2.2 Global Neurostimulation Devices Revenue and Market Share by Application (2016-2021)
2.3 Global Neurostimulation Devices (Volume and Value) by Regions
2.3.1 Global Neurostimulation Devices Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Neurostimulation Devices Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Neurostimulation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Neurostimulation Devices Consumption by Regions (2016-2021)
4.2 North America Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
4.10 South America Neurostimulation Devices Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Neurostimulation Devices Market Analysis
5.1 North America Neurostimulation Devices Consumption and Value Analysis
5.1.1 North America Neurostimulation Devices Market Under COVID-19
5.2 North America Neurostimulation Devices Consumption Volume by Types
5.3 North America Neurostimulation Devices Consumption Structure by Application
5.4 North America Neurostimulation Devices Consumption by Top Countries
5.4.1 United States Neurostimulation Devices Consumption Volume from 2016 to 2021
5.4.2 Canada Neurostimulation Devices Consumption Volume from 2016 to 2021
5.4.3 Mexico Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 6 East Asia Neurostimulation Devices Market Analysis
6.1 East Asia Neurostimulation Devices Consumption and Value Analysis
6.1.1 East Asia Neurostimulation Devices Market Under COVID-19
6.2 East Asia Neurostimulation Devices Consumption Volume by Types
6.3 East Asia Neurostimulation Devices Consumption Structure by Application
6.4 East Asia Neurostimulation Devices Consumption by Top Countries
6.4.1 China Neurostimulation Devices Consumption Volume from 2016 to 2021
6.4.2 Japan Neurostimulation Devices Consumption Volume from 2016 to 2021
6.4.3 South Korea Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 7 Europe Neurostimulation Devices Market Analysis
7.1 Europe Neurostimulation Devices Consumption and Value Analysis
7.1.1 Europe Neurostimulation Devices Market Under COVID-19
7.2 Europe Neurostimulation Devices Consumption Volume by Types
7.3 Europe Neurostimulation Devices Consumption Structure by Application
7.4 Europe Neurostimulation Devices Consumption by Top Countries
7.4.1 Germany Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.2 UK Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.3 France Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.4 Italy Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.5 Russia Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.6 Spain Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.7 Netherlands Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.8 Switzerland Neurostimulation Devices Consumption Volume from 2016 to 2021
7.4.9 Poland Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 8 South Asia Neurostimulation Devices Market Analysis
8.1 South Asia Neurostimulation Devices Consumption and Value Analysis
8.1.1 South Asia Neurostimulation Devices Market Under COVID-19
8.2 South Asia Neurostimulation Devices Consumption Volume by Types
8.3 South Asia Neurostimulation Devices Consumption Structure by Application
8.4 South Asia Neurostimulation Devices Consumption by Top Countries
8.4.1 India Neurostimulation Devices Consumption Volume from 2016 to 2021
8.4.2 Pakistan Neurostimulation Devices Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Neurostimulation Devices Market Analysis
9.1 Southeast Asia Neurostimulation Devices Consumption and Value Analysis
9.1.1 Southeast Asia Neurostimulation Devices Market Under COVID-19
9.2 Southeast Asia Neurostimulation Devices Consumption Volume by Types
9.3 Southeast Asia Neurostimulation Devices Consumption Structure by Application
9.4 Southeast Asia Neurostimulation Devices Consumption by Top Countries
9.4.1 Indonesia Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.2 Thailand Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.3 Singapore Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.4 Malaysia Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.5 Philippines Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.6 Vietnam Neurostimulation Devices Consumption Volume from 2016 to 2021
9.4.7 Myanmar Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 10 Middle East Neurostimulation Devices Market Analysis
10.1 Middle East Neurostimulation Devices Consumption and Value Analysis
10.1.1 Middle East Neurostimulation Devices Market Under COVID-19
10.2 Middle East Neurostimulation Devices Consumption Volume by Types
10.3 Middle East Neurostimulation Devices Consumption Structure by Application
10.4 Middle East Neurostimulation Devices Consumption by Top Countries
10.4.1 Turkey Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.3 Iran Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.5 Israel Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.6 Iraq Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.7 Qatar Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.8 Kuwait Neurostimulation Devices Consumption Volume from 2016 to 2021
10.4.9 Oman Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 11 Africa Neurostimulation Devices Market Analysis
11.1 Africa Neurostimulation Devices Consumption and Value Analysis
11.1.1 Africa Neurostimulation Devices Market Under COVID-19
11.2 Africa Neurostimulation Devices Consumption Volume by Types
11.3 Africa Neurostimulation Devices Consumption Structure by Application
11.4 Africa Neurostimulation Devices Consumption by Top Countries
11.4.1 Nigeria Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.2 South Africa Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.3 Egypt Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.4 Algeria Neurostimulation Devices Consumption Volume from 2016 to 2021
11.4.5 Morocco Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 12 Oceania Neurostimulation Devices Market Analysis
12.1 Oceania Neurostimulation Devices Consumption and Value Analysis
12.2 Oceania Neurostimulation Devices Consumption Volume by Types
12.3 Oceania Neurostimulation Devices Consumption Structure by Application
12.4 Oceania Neurostimulation Devices Consumption by Top Countries
12.4.1 Australia Neurostimulation Devices Consumption Volume from 2016 to 2021
12.4.2 New Zealand Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 13 South America Neurostimulation Devices Market Analysis
13.1 South America Neurostimulation Devices Consumption and Value Analysis
13.1.1 South America Neurostimulation Devices Market Under COVID-19
13.2 South America Neurostimulation Devices Consumption Volume by Types
13.3 South America Neurostimulation Devices Consumption Structure by Application
13.4 South America Neurostimulation Devices Consumption Volume by Major Countries
13.4.1 Brazil Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.2 Argentina Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.3 Columbia Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.4 Chile Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.5 Venezuela Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.6 Peru Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Neurostimulation Devices Consumption Volume from 2016 to 2021
13.4.8 Ecuador Neurostimulation Devices Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Neurostimulation Devices Business
14.1 Medtronic
14.1.1 Medtronic Company Profile
14.1.2 Medtronic Neurostimulation Devices Product Specification
14.1.3 Medtronic Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Boston Scientific
14.2.1 Boston Scientific Company Profile
14.2.2 Boston Scientific Neurostimulation Devices Product Specification
14.2.3 Boston Scientific Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 St. Jude Medical (Abbott)
14.3.1 St. Jude Medical (Abbott) Company Profile
14.3.2 St. Jude Medical (Abbott) Neurostimulation Devices Product Specification
14.3.3 St. Jude Medical (Abbott) Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 LivaNova
14.4.1 LivaNova Company Profile
14.4.2 LivaNova Neurostimulation Devices Product Specification
14.4.3 LivaNova Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Nevro
14.5.1 Nevro Company Profile
14.5.2 Nevro Neurostimulation Devices Product Specification
14.5.3 Nevro Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 NeuroPace
14.6.1 NeuroPace Company Profile
14.6.2 NeuroPace Neurostimulation Devices Product Specification
14.6.3 NeuroPace Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Beijing Pins
14.7.1 Beijing Pins Company Profile
14.7.2 Beijing Pins Neurostimulation Devices Product Specification
14.7.3 Beijing Pins Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Synapse Biomedical
14.8.1 Synapse Biomedical Company Profile
14.8.2 Synapse Biomedical Neurostimulation Devices Product Specification
14.8.3 Synapse Biomedical Neurostimulation Devices Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Neurostimulation Devices Market Forecast (2022-2027)
15.1 Global Neurostimulation Devices Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Neurostimulation Devices Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Neurostimulation Devices Value and Growth Rate Forecast (2022-2027)
15.2 Global Neurostimulation Devices Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Neurostimulation Devices Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Neurostimulation Devices Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Neurostimulation Devices Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Neurostimulation Devices Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Neurostimulation Devices Consumption Forecast by Type (2022-2027)
15.3.2 Global Neurostimulation Devices Revenue Forecast by Type (2022-2027)
15.3.3 Global Neurostimulation Devices Price Forecast by Type (2022-2027)
15.4 Global Neurostimulation Devices Consumption Volume Forecast by Application (2022-2027)
15.5 Neurostimulation Devices Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Published On:11/08/2021
Base Year:
Historical Data:
No of Pages:123
Price
Global Neurostimulation Devices Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
